PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)

Purpose

The goal of this clinical trial is to learn if use of the PEPPI software can improve pharmacist-provided HIV prevention (PEP/PrEP) services. The main questions it aims to answer are: 1. Does the PEPPI software make it easier for pharmacists to provide PEP/PrEP services in their pharmacy? 2. Does the PEPPI software make it easier for patients to access PEP/PrEP? Researchers will compare pharmacists' implementation and patients' access when using the PEPPI software and when not using the PEPPI software to see if the software improves implementation and access. Participants will include pharmacists and patients. Pharmacists will be asked to provide PEP/PrEP services as normal while using the PEPPI software. Patients will be asked to receive PEP/PrEP services from a pharmacist as normal, while using the PEPPI software.

Conditions

  • HIV Prevention
  • HIV Pre-exposure Prophylaxis
  • Access and Linkage to Healthcare
  • Technology Use

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 18 years of age or older - Provide, or willing to provide, PEP/PrEP services in a participating pharmacy - Use the PEPPI software to provide birth control services

Exclusion Criteria

  • None PATIENT Participants Inclusion Criteria: - 18 years of age or older - Seek PEP or PrEP services at a participating pharmacy - Use the PEPPI software to receive PEP/PrEP services at a participating pharmacy Exclusion Criteria: - NONE

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Health Services Research
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Other
PEPPI Pharmacies
This is a single-arm trial, so all pharmacies will serve as their own control. We will enroll 10 community pharmacies. These 10 pharmacies will continue to provide PEP/PrEP services as normal for several months (control). Then, we will introduce the first phase of the intervention: the minimally viable product (MVP) version of the PEPPI software. The second phase of the intervention will be the enhanced version of the PEPPI software. The pharmacies will continue to provide PEP/PrEP services while using the PEPPI software in place of any paper or electronic processes that they were previously using. The results will then be compared between the control and the intervention periods.
  • Other: PEPPI Pharmacies
    We will enroll 10 community pharmacies. These 10 pharmacies will continue to provide PEP/PrEP services as normal for several months (control). Then, we will introduce the first phase of the intervention: the minimally viable product (MVP) version of the PEPPI software. The second phase of the intervention will use the enhanced version of the PEPPI software. The pharmacies will continue to provide PEP/PrEP services while using the PEPPI software in place of any paper or electronic processes that they were previously using. The results will then be compared between the control and the intervention periods.

Recruiting Locations

EmpoweRx, Inc
Del Mar, California 92014
Contact:
Sally Rafie, PharmD
8584120984
sally@birthcontrolpharmacist.com

More Details

Status
Recruiting
Sponsor
EMPOWERX INC

Study Contact

Jenny L Newlon, PharmD, PhD
8584120984
jenny@birthcontrolpharmacist.com